首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6507篇
  免费   311篇
  国内免费   74篇
耳鼻咽喉   5篇
儿科学   104篇
妇产科学   33篇
基础医学   818篇
口腔科学   11篇
临床医学   878篇
内科学   2312篇
皮肤病学   10篇
神经病学   162篇
特种医学   251篇
外科学   140篇
综合类   968篇
预防医学   575篇
眼科学   5篇
药学   439篇
  7篇
中国医学   153篇
肿瘤学   21篇
  2024年   7篇
  2023年   65篇
  2022年   121篇
  2021年   192篇
  2020年   183篇
  2019年   133篇
  2018年   224篇
  2017年   159篇
  2016年   160篇
  2015年   144篇
  2014年   431篇
  2013年   426篇
  2012年   304篇
  2011年   387篇
  2010年   321篇
  2009年   267篇
  2008年   353篇
  2007年   346篇
  2006年   301篇
  2005年   231篇
  2004年   200篇
  2003年   189篇
  2002年   184篇
  2001年   148篇
  2000年   141篇
  1999年   122篇
  1998年   109篇
  1997年   141篇
  1996年   132篇
  1995年   122篇
  1994年   95篇
  1993年   56篇
  1992年   69篇
  1991年   47篇
  1990年   53篇
  1989年   36篇
  1988年   33篇
  1987年   31篇
  1986年   29篇
  1985年   45篇
  1984年   37篇
  1983年   22篇
  1982年   19篇
  1981年   18篇
  1980年   9篇
  1979年   11篇
  1978年   16篇
  1977年   5篇
  1976年   6篇
  1975年   4篇
排序方式: 共有6892条查询结果,搜索用时 0 毫秒
11.
A simple, cost effective circuit for a two-electrode non-differential biopotential amplifier is proposed. It uses a ‘virtual ground’ transimpedance amplifier and a parallel RC network for input common mode current equalisation, while the signal input impedance preserves its high value. With this innovative interface circuit, a simple non-inverting amplifier fully emulates high CMRR differential. The amplifier equivalent CMRR (typical range from 70–100 dB) is equal to the open loop gain of the operational amplifier used in the transimpedance interface stage. The circuit has very simple structure and utilises a small number of popular components. The amplifier is intended for use in various two-electrode applications, such as Holter-type monitors, defibrillators, ECG monitors, biotelemetry devices etc.  相似文献   
12.
The effects of oestrogen therapy and of orchidectomy on coronarystauts, as reflected by exercise ECG-testing before and afteryear of tretment, were assessed in a randomized study of patients(N=100) prostatic cancer. Oestrogen was given as polyestradiolphosphate 80 mg i.m. per month in combination with 150 µgor in pre-traetment exercise test results Twelve months afterstart of therapy the oestrogen group showed a significantlygreater depression of the ST-segment during maximal exercisein leads CH2 (P<0.0005) and CH5)P<0.01) compared withthe pre-treatment depression. Twenty-five per cent (N=13) ofthe patients in the oestrogen group suffered cardiovascularcomplications during the yera the of therapy, whereas no suchcomplications were observed in the orchidectomy group. However,even the patients in the oestrogen group who had not sufferedcardiovascular complications had significantly greater depressionsof the ST-segment during exercise both in lead CH2 (P<0.0005)and in CH5 (P<0.05). There was no significant change in theST-segment level in the orchidectomy group twelve months aftersurgery. In summary, we found of an induction of myocardialishaemia during treatment with exogenous oestrogens at low dosagein patients with prostatic. This deleterious effect of oestrogenon the coronary status argues against oestrogen therapy, sinceoedtrogen has not been shown to be more beneficial than orhidectomyagainst prostatic carcinoma.  相似文献   
13.
本文介绍我们近年研制成功的一种全新的微型化的心电监视仪。该仪器集主机,显示器,电极导联于一体,适合医务人员随身携带,用于需要快速、简易、准确地获取人体心电图形与心率数据的场合。  相似文献   
14.
人工神经网络预滤波的自适应运动心电信号增强器   总被引:3,自引:0,他引:3  
运动心电图是一种将人体对象置于非平静状态下检测到的心电信号,其特点是运动导致基线严重漂移,肌电干扰显著增加,信噪比低。介绍了一种用人工神经网络预滤波的自适应运动心电信号增强器。运用人工神经网络的非线性和自适应处理的跟踪特性有机地结合设计而成。能降低噪声,提高信噪比,有效地提取运动心电信号。  相似文献   
15.
为了解QTcd、JTcd在心电图活动平板运动试验结果判断中的价值 ,对 10 0例活动平板运动试验阳性者及 80例阴性者运动前后的心电图QTcd、JTcd进行对比观察。结果表明 :运动前两组QTcd、JTcd差异均无显著性 ( P〉0 .0 5 ) ;运动后 2min运动试验阳性组与阴性组比较 ,QTcd、JTcd差异有高度显著性 (P <0 .0 1) ;阳性组运动试验后 2minQTcd、JTcd均较运动前显著延长 ( P <0 .0 1) ;阴性组运动后 2minQTcd、JTcd与运动前比较差异无显著性 ( P >0 .0 5 )。认为运动试验后QTcd、JTcd延长可作为判断运动试验结果的指标。  相似文献   
16.
目的:探讨肺心病患者的心电图改变。方法:对196例肺心病患者的心电图进行分析。结果:196例中心电图异常者187例,达总数的954%,其中PtfV1异常者达163%。结论:肺心病可产生多种心电图异常,其中肺心病PtfV1异常应引起重视。  相似文献   
17.
Summary The effect of treatment for 1–4 weeks with metoprolol, a 1-selective blocking agent, or alprenolol, on the heart rate and blood pressure response to isometric exercise was studied in two groups of 12 patients with angina. Measurements were made during the peak effect of metoprolol 10, 40 or 50 mg, and alprenolol 200 mg as Aptin® Durules®. After 1 min of sustained handgrip at 50% of maximal voluntary contraction, systolic (6–15%) and diastolic (8–12%) blood pressure after both drugs was significantly lower than without any -blockade; Heart rate was decreased by 19–22% by metoprolol but not by alprenolol. The blood pressurerise during handgrip was not attenuated by either drug. The rise in heart rate was significantly reduced (by 36–50%) by metoprolol 40 and 50 mg and alprenolol 200 mg. No patient experienced angina during handgrip. In contrast, all but one were restricted by angina during bicycle exercise without treatment, at a level that produced the same increase in heart rate as the handgrip test, viz. 3 min at a load of 33 W). The cardiovascular response to sustained handgrip is too small to provide a useful challenge for determination of the anti-anginal efficacy of drugs. However, slight ECG changes of ischaemia did occur during handgrip, which were reversed by -blockade.  相似文献   
18.
目的 :了解和比较利培酮与氯丙嗪对心电图的影响。方法 :对服用利培酮及氯丙嗪的精神分裂症患者分别定期心电图检查 ,时间为服药后 2、4周。结果 :利培酮组和氯丙嗪组出现异常分别为 11.5 %和 4 2 .5 % ,两者有显著性差异 (P <0 .0 5 )。结论 :利培酮对心电图影响明显低于氯丙嗪。  相似文献   
19.
A child with considerable electrocardiographic (ECG) repolarization abnormalities is reported in whom, after clinical and hemodynamic evaluation, only a large muscular false tendon within the left ventricular cavity was found. The genesis of the ECG changes in such cases is discussed, and the differential diagnosis from apical hypertrophic cardiomyopathy is analyzed.  相似文献   
20.
Rationale:The treatment of dilated cardiomyopathy (DCM) has recently been greatly improved, especially with the widespread use of sacubitril/valsartan (ARNI) combination therapy. We know that ARNI-like drugs can significantly improve the symptoms of heart failure with reducing ejection fraction. However, clinical studies evaluating the safety and efficacy of ARNI in DCM-associated arrhythmia are limited, and whether individuals with arrhythmia would benefit from ARNI remains controversial. In this case, we report a patient with complete left bundle branch block (CLBBB) associated with DCM whose CLBBB returned to normal after treatment with ARNI.Patient concerns:A 38-year-old man was admitted to the hospital for 20 days for idiopathic paroxysmal dyspnea. He presented with exacerbated dyspnea symptoms at night, accompanied by cough and sputum.Diagnosis:Physical examination revealed a grade 4/6 systolic murmur could be heard in the apical area of the heart and mild edema was present in both lower limbs. Laboratory examination found that the B-type natriuretic peptide was significantly increased. Echocardiography indicated left atrial internal diameter, right ventricular internal diameter, and left ventricular diastolic diameter were enlarged and ejection fraction was significantly decreased. Besides, the pulsation of the wall was diffusely attenuated. Electrocardiogram was suggestive of tachycardia and CLBBB. A diagnosis of DCM with CLBBB was considered based on a comprehensive evaluation of the physical examination, laboratory examination, echocardiography and electrocardiogram.Interventions:The patient was treated with ARNI at a dose of 50 mg (twice a day) at first, gradually increasing to the target dose (200 mg, twice a day) in the following 9 months as shown in Table Table1,1, along with metoprolol 25 mg (once a day [qd]), diuretics 20 mg (qd), and aldosterone 20 mg (qd).Table 1Specific medications used in treatment.
Month(s) and dates after dischargeMorning (ARNI)Night (ARNI)Metoprolol 23.75 mg QD;
diuretics (furosemide) 20 mg QD;
aldosterone 20 mg QD
Month 1 (28/02/20–27/03/20)50 mg50 mg
Month 2 (27/03/20–26/04/20)100 mg50 mg
Month 3–4 (26/04/20–28/06/20)100 mg100 mg
Months 5–7 (28/05/20–29/08/20)150 mg100 mg
Months 8–11 (29/08/20–13/11/20)150 mg150 mg
Month 11–present (13/11/20–)200 mg200 mg
Open in a separate windowARNI = sacubitril/valsartan, QD = once a day.Outcomes:After treatment with ARNI during the 9-month follow-up, the patient’s symptoms improved, and CLBBB returned to normal.Lessons:Clinical studies evaluating the safety and efficacy of ARNI in DCM-associated arrhythmia are limited, and whether individuals with arrhythmia would benefit from ARNI remains controversial. This report will help to instruct the clinical treatment of DCM patients with CLBBB and the potential application of ARNI.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号